UNHUNHHealthcare · Healthcare Plans

UNH Stock Forecast: UnitedHealth Group, Inc. Price Predictions for 2026-2027

Last close, 3 Sept 2026
$401
+0.32% on the day

The 27 Wall Street analysts covering UnitedHealth Group, Inc. hold a median 12-month price target of $490 — +22.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 75 of 100 as at 2 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$358.7B
Ticker Nerd rank
75 / 100
Median analyst target
$490
Analysts covering
27
Revenue$111.7B+2.0% y/y
Operating income$9.0B
Net income$6.5B
Free cash flow$8.1B
Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.5%
1M
−3.5%
YTD
+23.1%
1Y
+33.7%
From 52W high
−8.1%
From 52W low
+55.7%
$258
$436
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

UNH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores UnitedHealth Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Sept 2026
75 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
92
Issuance
90
Volatility
89
Value
77
Momentum
72
Accruals
54
Quality
43
Growth
38
Size
1

Revisions (92): Analysts have, on balance, been raising their forecasts.

Growth (38): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (1): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

UNH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UNH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$200$300$400$500$600Oct 25Jan 26Apr 26Jul 26UNHHigh $529Median $490Low $313

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says27 analysts
23 Buy4 Hold0 Sell
Low $313Median $490High $529

The green dot is the last close — the median target sits +22.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 16 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
21 July 2026JP MorganMaintainsOverweight$466$516
21 July 2026MizuhoMaintainsOutperform$470$493
20 July 2026BarclaysMaintainsOverweight$429$441
17 July 2026KeybancMaintainsOverweight$475$500
17 July 2026Morgan StanleyMaintainsOverweight$468$529
17 July 2026OppenheimerMaintainsOutperform$420$500
17 July 2026RBC CapitalMaintainsOutperform$463$478
17 July 2026Truist SecuritiesMaintainsBuy$480$500
17 July 2026UBSMaintainsBuy$460$490
16 July 2026BairdUpgradeNeutral$287$453
14 July 2026KeybancMaintainsOverweight$400$475
14 July 2026TD CowenMaintainsHold$337$430
14 July 2026Truist SecuritiesMaintainsBuy$440$480
13 July 2026Wells FargoMaintainsOverweight
13 July 2026Wells FargoMaintainsOverweight$397$485
9 July 2026RBC CapitalMaintainsOutperform$400$463
9 July 2026RBC CapitalMaintainsOutperform
6 July 2026HSBCMaintainsHold$300$380
6 July 2026HSBCMaintainsHold
30 June 2026Morgan StanleyMaintainsOverweight

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. UNH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

UNH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 3 Sept 2026, UnitedHealth Group, Inc. returned +33.7% against +21.4% for the S&P 500, dividends included.

UNH vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140150Oct 25Jan 26Apr 26Jul 26UNHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

UNH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+7.9%
Analysts raising
24
Analysts cutting
0
Fundamentals

UnitedHealth Group, Inc. (UNH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
25.4×

Cheaper than 30% of US stocks

Price / sales
0.8×

Cheaper than 74% of US stocks

Price / book
3.7×

Cheaper than 29% of US stocks

EV / EBITDA
15.3×

Cheaper than 23% of US stocks

Growth & margins
Revenue growth (YoY)
0.4%

Higher than 28% of US stocks

Earnings growth (YoY)
61.0%

Higher than 78% of US stocks

Gross margin
22.7%

Higher than 25% of US stocks

Operating margin
7.1%

Higher than 59% of US stocks

Net margin
3.1%

Higher than 55% of US stocks

Returns & dividend
Return on equity
14.2%

Higher than 73% of US stocks

Return on assets
4.9%

Higher than 75% of US stocks

Dividend yield
2.3%

Higher than 51% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

UnitedHealth Group, Inc. (UNH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • UnitedHealth Group, Inc. has a market value of $358.7B and an enterprise value of $408.1B.

  • Revenue in the twelve months to 31 Mar 2026: $449.7B. The latest quarter grew 0.4% year on year.

  • Net income over the same four quarters: $12.8B, a 2.8% net margin.

  • Diluted earnings per share, trailing twelve months: $13.24.

  • Free cash flow in the twelve months to 31 Mar 2026: $19.7B, after $3.5B of capital spending.

  • UnitedHealth Group, Inc. spent $2.5B on share buybacks and $8.0B on dividends in the twelve months to 31 Mar 2026.

  • Shares outstanding: 907.7M.

  • Trailing P/E: 25.4×; forward P/E: 17.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.32%, paying out 58% of earnings.

  • UnitedHealth Group, Inc. employs 390,000 people $1.2M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 3 Sept 2026

Data provided by Twelve Data

Peers

UNH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
UNHUnitedHealth Group, Inc.$358.7B
75
CVSCVS Health Corp.$123.4B
87
ELVElevance Health, Inc.$90.2B
68
CIThe Cigna Group$74.7B
71
HUMHumana, Inc.$48.2B
46
CNCCentene Corp.$33.1B
94
MRKMerck & Co., Inc.*$376.4B
82

* Nearest Healthcare names by size — few healthcare plans companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own UnitedHealth Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest UNH news & analysis

3 Sector Stocks to Gain From as Oil, Rates and Jobs Shape September

Zacks Investment Research · 3 Sept 2026positive

A Zacks Investment Research report suggests September's rate and oil pressures could drive sector rotation, favoring energy, financials and defensive healthcare stocks over growth stocks. The article positions defensive healthcare as one of the sectors likely to gain in this environment.

Why it matters — UnitedHealth is a defensive healthcare company that could benefit from sector rotation if investors shift away from growth stocks in September.

Is UnitedHealth Finally Turning the Corner After a Tough 2025?

Zacks Investment Research · 3 Sept 2026positive

UnitedHealth (UNH) is showing signs of recovery, with improving medical costs, momentum at its Optum business, and higher 2026 earnings guidance after a difficult 2025.

Why it matters — A UNH watcher would care because these signals suggest the company's financial headwinds may be easing into 2026.

How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?

Zacks Investment Research · 3 Sept 2026positive

Zacks reports that rising employer healthcare costs could create growth opportunities for UnitedHealth and Centene through cost-control solutions, while also potentially boosting demand for Marsh's consulting services.

Why it matters — A UNH watcher would care because escalating healthcare costs may drive greater demand for UnitedHealth's cost-management and care-solution offerings, supporting its growth prospects.

Dogs Of The Dow: No Buys And Few Worth Watching

Seeking Alpha · 3 Sept 2026neutral

A Seeking Alpha analysis of the "Dogs of the Dow" strategy finds the group remains generally overvalued, with none of the stocks currently meeting the ideal fair-price threshold. The report notes that analyst forecasts project average gains of 28.46% for the top ten Dow Dogs by September 2027, while suggesting current conditions favor waiting for price pullbacks or dividend increases before entering yield-based positions.

Why it matters — As a Dow component, UNH watchers would care because the analysis evaluates yield-based Dow strategies and current valuation conditions that affect how the stock might fit into such an approach.

Brokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet

Zacks Investment Research · 2 Sept 2026neutral

The article discusses how investors frequently rely on Wall Street analysts' recommendations when deciding whether to buy, sell, or hold a stock, and notes that media reports about brokerage-firm-employed analysts changing their ratings can affect a stock's price. It frames this in the context of UnitedHealth (UNH).

Why it matters — UNH watchers would care because analyst rating changes and media coverage of those recommendations can influence the company's stock price and investor sentiment.

FAQ

Frequently asked questions about UNH stock

What is the UNH stock price forecast for 2026-2027?

The 27 Wall Street analysts covering UnitedHealth Group, Inc. have a median 12-month price target of $490, with estimates ranging from $313 to $529. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is UNH stock a buy right now?

Of the 27 analysts covering UnitedHealth Group, Inc., 23 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks UnitedHealth Group, Inc. 75 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank UNH?

As at 2 Sept 2026, UnitedHealth Group, Inc. ranks 75 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (92 of 100).

Will UNH stock go up?

No one can know that. What the data says: the median 12-month target from 27 analysts implies +22.2% from the last close, and Ticker Nerd's factor model ranks UnitedHealth Group, Inc. 75 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the UNH stock forecast for 2030?

No analyst covering UnitedHealth Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UNH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $313 to $529 over the next 12 months.

How has UNH stock performed over the past year?

UnitedHealth Group, Inc. returned +33.7% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does UnitedHealth Group, Inc. do?

UnitedHealth Group Inc. is a diversified health care company that provides health benefits, care delivery, pharmacy services, and data-driven health services.

What is the latest news on UNH?

The most recent item we track (Zacks Investment Research, 3 Sept 2026): "3 Sector Stocks to Gain From as Oil, Rates and Jobs Shape September". A Zacks Investment Research report suggests September's rate and oil pressures could drive sector rotation, favoring energy, financials and defensive healthcare stocks over growth stocks. The article positions defensive healthcare as one of the sectors likely to gain in this environment.

Company

About UnitedHealth Group, Inc.

UnitedHealth Group Inc. is a diversified health care company that provides health benefits, care delivery, pharmacy services, and data-driven health services. The company operates through UnitedHealthcare and Optum, serving individuals, employers, government programs, and health care organizations with products and services that span medical coverage, care management, prescription benefit solutions, and health technology tools. UnitedHealthcare focuses on health insurance and benefit administration across commercial, Medicare, Medicaid, and specialty markets, while Optum supports clinical care, pharmacy services, analytics, consulting, and administrative solutions for the broader health system. UnitedHealth Group plays a central role in the U.S. health care market by connecting coverage, care, and information services across multiple parts of the industry. Founded in 1974 and headquartered in Eden Prairie, Minnesota, the company remains one of the most prominent participants in managed health care and health services.

CEO Mr. Stephen J. Hemsley · 390,000 employees · United States · https://www.unitedhealthgroup.com